OBJECTIVE -With the current obesity epidemic, one would expect a prevalence increase in the metabolic syndrome. Therefore, in the San Antonio Heart Study, a population-based study with worsening obesity, we examined the metabolic syndrome and its effect on incident cardiovascular disease (CVD). : 1979 -1982 and 1984 -1988. We reexamined 3,682 (71.4%) subjects in 1987-1990 (cohort 1) and 1991-1996 (cohort 2) and assessed a 7.5-year incidence of CVD in 4,635 (90.0%) participants. We used the metabolic syndrome definition of the National Cholesterol Education Program-Adult Treatment Panel III.
I
n the U.S. population, obesity has reached epidemic proportions. In the National Health and Nutrition Examination Survey (NHANES) 1999 -2000, 64.5% of subjects aged 20 -74 years are overweight or obese (1) . Similar trends have been demonstrated for abdominal obesity (2) and type 2 diabetes (3). Abdominal obesity is a central element of the metabolic syndrome (4, 5) and a strong predictor of incident metabolic syndrome (4) . Thus, it has been hypothesized that the prevalence of the metabolic syndrome has increased in the U.S. population (6, 7) Despite alarming trends in obesity and diabetes, trends in other individual metabolic disorders have been more favorable. Hypertension had been declining before 1988 -1991 (8) but may be increasing in recent years (9) . HDL cholesterol levels have been reported without significant changes (10) . Nevertheless, there is little information regarding the effect of those trends on the prevalence of the metabolic syndrome as well as on cardiovascular disease (CVD) risk, particularly in view of the continuing decline in CVD mortality (11) .
In this report, we examined the prevalence of the metabolic syndrome in the San Antonio Heart Study (SAHS), a population-based study with alreadycharacterized adverse trends in obesity (12) and type 2 diabetes (13) . We also assessed the effect of the metabolic syndrome on incident CVD.
RESEARCH DESIGN AND METHODS -The SAHS targeted
Mexican-American and non-Hispanic white inhabitants of San Antonio. Study protocols were approved by the institutional review board of the University of Texas Health Science Center at San Antonio. All subjects gave written informed consent. Detailed descriptions of this study have been published (13, 14) . Briefly, all men and nonpregnant women aged 25-64 years residing in randomly selected households from low-, middle-, and high-income census tracts were considered eligible for participation. A total of 5,158 individuals (response rate was 65.3%) were enrolled in two phases: cohort 1, from January 1979 to December 1982 and cohort 2, from January 1984 to December 1988 (14) . Of those, 3,682 (71.4%) participants returned to a follow-up examination: cohort 1, between October 1987 and November 1990 (median 8.0 years) and cohort 2, between October 1991 and October 1996 (median 7.4 years) (13) . Incident CVD was assessed in 4,635 (90.0%) participants. In 3,581 subjects, assessment was carried out by interview at the follow-up examination or by death certificate. In 1,054 subjects who did not return to the follow-up examination, assessment was accomplished by telephone or home interview. Acquisition of data and definition of variables and outcomes Socioeconomic status was assessed at baseline by Duncan's socioeconomic index, a global measure based on occupational prestige (15) . Waist circumference was measured at the level of the umbilicus. Systolic (1st phase) and diastolic (5th phase) blood pressure were recorded with a random-zero sphygmomanometer (Hawksley-Gelman, Sussex, U.K.), with the participant in the sitting position. They were reported as the mean of the second and third blood pressure readings. Blood specimens were obtained after a 12-to 14-h fast. A 75-g oral glucose load (Orangedex; Custom Laboratories, Baltimore, MD) was administered to determine the 2-h glucose value. Plasma glucose and serum lipids were measured with an Abbott Bichromatic Analyzer (South Pasadena, CA) in the laboratory of the Division of Clinical Epidemiology in San Antonio (13, 14) . LDL cholesterol level was calculated using the Friedewald formula in samples with triglyceride levels Ͻ4.5 mmol/l. We examined diabetes status using the 1999 criteria of the World Health Organization (16) . We defined history of CVD as self-reported heart attack, stroke, coronary revascularization procedure, or angina (by Rose Angina questionnaire) at baseline (17) and incident CVD as selfreported heart attack, stroke, or coronary revascularization procedure at follow-up or any mention of cardiovascular death on the death certificate (ICD-9 codes 390 -459) (18) . We used the Framingham risk equations to estimate the 10-year coronary heart disease risk (19) and the National Cholesterol Education ProgramAdult Treatment Panel III (ATPIII) definition of the metabolic syndrome (20) . This definition required three or more of the following criteria: elevated waist circumference (Ͼ102 cm in men and Ͼ88 cm in women), hypertriglyceridemia (Ն1.7 mmol/l), low HDL cholesterol (Ͻ1.0 mmol/l in men and Ͻ1.3 mmol/l in women), high blood pressure (Ն130/85 mmHg or pharmacological treatment for hypertension), and elevated fasting glucose (Ն5.6 mmol/l or pharmacological treatment for diabetes) (20) .
Since waist circumference was not measured in cohort 1 at baseline (1979 -1982), we used cohort 2 baseline data (1984 -1988) to develop sex-specific logistic regression equations to predict waist circumference from log-transformed weight and height and ethnic origin. We selected the cut point that maximized sensitivity plus specificity. We used imputed elevated waist circumference to generate the prevalence of the metabolic syndrome in 1979 -1982. To validate our approach, we imputed elevated waist circumference using the selected cut points in cohort 1 follow-up data (1987) (1988) (1989) (1990) . Agreement between ATPIII and imputed cut points for waist circumference was high ( statistic ϭ 0.69 [95% CI 0.66 -0.73]). Agreement between ATPIII-defined (prevalence, 34.3%) and imputed (prevalence, 36.2%) metabolic syndrome was very high ( statistic ϭ 0.91 [0.89 -0.93]).
Data analysis
We performed statistical analyses with the SAS statistical software system version 8.0 (SAS Institute, Cary, NC). We evaluated incident CVD and baseline differences in dichotomous variables by multiple logistic regression analysis. We assessed baseline differences in continuous variables or the logarithm of the odds for Framingham risk estimates of coronary heart disease events over 10 years by one-way ANCOVA. We examined prevalence trends and compared the prevalence of the metabolic syndrome (or individual disorders) between baseline and follow-up by GENMOD, a procedure that fits generalized linear models. GENMOD with the logit link was able to account for the fact that follow-up data represented repeated measurements of the same individuals. Age squared was included as one of the covariates to allow for a nonlinear association between age and the dependent variable. We used the statistic to ascertain agreement between ATPIII-defined and imputed waist circumference (or metabolic syndrome). All probability values were two sided.
RESULTS -Compared with cohort 1, many baseline characteristics were different in cohort 2 ( Table 1) . In cohort 2, low HDL cholesterol and high blood pressure were more frequent, and total cholesterol levels and smoking rates were lower. Elevated fasting glucose was less frequent, but type 2 diabetes was equally prevalent. Additionally, elevated waist circumference was more common in cohort 2 women than in cohort 1 women. From baseline to follow-up, elevated waist circumference and low HDL cholesterol became more prevalent and smoking less frequent. Elevated fasting glucose and type 2 diabetes and total cholesterol levels also became more common in cohort 2 but less in cohort 1. Data are odds ratio (95% CI). *P value was adjusted for age, age squared, ethnic origin, and socioeconomic status and accounted for the fact that follow-up data were repeated measurements of the same individuals. †P value was adjusted for age, age squared, ethnic origin, and socioeconomic status. ‡Prevalence calculated using elevated waist circumference imputed from weight, height, sex, and ethnic origin.
At baseline, the metabolic syndrome was more frequent in cohort 2 than in cohort 1 ( Table 2) . This difference was statistically significant in men and women of both ethnic groups (Table 3 ) and in most of the considered age-groups in both men (30 -39 years, P ϭ 0.474; 40 -49 years, P ϭ 0.028; 50 -59 years, P Ͻ 0.001) and women (30 -39 years, P ϭ 0.032; 40 -49 years, P Ͻ 0.001; 50 -59 years, P Ͻ 0.001) (Fig. 1) . During the enrollment years (between 1979 and 1988), the odds for enrolling a subject with the metabolic syndrome went up 7.6% per year in men (95% CI 3.7-11.6) and 9.9% per year in women (6.1-13.8). Similarly, the prevalence of the metabolic syndrome was higher at follow-up than at baseline in both cohorts (Tables 2 and 3 ; Fig. 1 ). When we examined both cohorts together, there was a rapid rise from 1979 -1982 to 1991-1996 (Table 3 (differences presented in the figure) . Because diabetes could inflate the prevalence of individual metabolic disorders and drive much of the CVD risk, we performed similar analyses among nondiabetic subjects. At baseline, the metabolic syndrome was less prevalent in cohort 1 than in cohort 2 ( Because of the SAHS design (two independent cohorts each examined at two points), a potential source of bias in the assessment of trends was the possibility of baseline differences between participants who returned to follow-up and those who did not. Return rates were lower in cohort 1 diabetic men (P ϭ 0.001) and women (P Ͻ 0.001) and in cohort 1 women with elevated fasting glucose (P ϭ 0.030) or the metabolic syndrome (P ϭ 0.018) after the adjustment for age, ethnic origin, and socioeconomic status. Additionally, return rates were also lower in cohort 1 men (P ϭ 0.033) and cohort 2 women (P ϭ 0.027), with low HDL cholesterol levels and in cohort 1 (P ϭ 0.040) and cohort 2 women (P ϭ 0.010) with high blood pressure.
CONCLUSIONS -In San Antonio, Texas, worsening obesity is associated with a rapid rise in the prevalence of the metabolic syndrome. This increase is present in most of the considered agegroups, in men and women, in Mexican Americans and non-Hispanic whites, and in diabetic and nondiabetic individuals. Moreover, the metabolic syndrome has had a negative effect on CVD incidence.
Ford et al. (6) have already described an increase in the prevalence of the metabolic syndrome in the U.S. population aged Ն20 years between 1988 -1994 and 1999 -2000. The increase is statistically significant in women (from 27.0 to 32.9%, P ϭ 0.014) but not in men (from 31.4 to 31.8%, P ϭ 0.866), even though a prevalence increase of elevated waist circumference is demonstrated in both sexes (2, 6) . Further studies are needed because sample size is considerably smaller in the NHANES 1999 -2000 than the other survey. Besides, a simultaneous increase in obesity and the metabolic syndrome is not always present, as we have recently reported in the Mexico City Diabetes Study (21) . In San Antonio, there is a higher prevalence of the metabolic syndrome in cohort 2 than in cohort 1. It is likely that this represents an increase with time, from 1978 -1982 to 1984 -1988, because both cohorts are cross-sectional surveys of the population in San Antonio. The increase is observed across all agegroups, in men and women, in Mexican Americans and non-Hispanic whites, and in diabetic and nondiabetic subjects. Based on follow-up results, we can also speculate that the prevalence has increased from 1979 -1982 to 1991-1996. Similar to the increase in the prevalence or the metabolic syndrome, Framingham risk scores have also increased. Scores have worsened because changes in blood pressure and HDL cholesterol levels have outrun improvements in smoking rates and total cholesterol levels. Moreover, CVD incidence has also gone up partially because of the increase in the prevalence of the metabolic syndrome.
In San Antonio, prevalence changes in many of the CVD risk factors are similar to reported changes in the U.S. population. Obesity (1,2), diabetes (3, 8) , and hypertriglyceridemia (22) are increasing, while smoking rates are decreasing (8) . Improvement in total cholesterol levels is observed in the SAHS before 1984 -1988 but not between 1984 -1988 and 1991-1996 . Similar changes have been described in the NHANES (improvement before 1988 -1994 and no changes between 1988 -1994 and 1999 -2000) (23) and in the Minnesota Heart Survey (24) . In contrast, the SAHS differs from the NHANES regarding changes in HDL cholesterol levels and blood pressure. HDL cholesterol levels have worsened in the SAHS but have improved slightly in the NHANES (22) . Two other studies also described opposite changes in HDL cholesterol levels: the Minnesota Heart Survey (24) reports no changes, and a study from New England (25) reports decreasing levels. Similarly, the prevalence of high blood pressure has increased in the SAHS before 1984 -1988 but not between 1984 -1988 and 1991-1996 , whereas hypertension prevalence has decreased in the NHANES before 1988 -1991 (8) and increased between 1988 -1991 and 1999 -2000 (9) . HDL cholesterol levels and blood pressure have been partially responsible for the CVD risk increase in San Antonio. Therefore, we cannot infer from our results that a similar change in CVD risk has occurred in the U.S. population.
Prevalence differences in elevated fasting glucose are particularly surprising. The decline between 1979 -1982 and 1984 -1988 coincides with increases in BMI and the prevalence of the metabolic syndrome as well as with similar diabetes rates. We have no explanation for this result except for differences in the diabetes conversion rate (13) . However, no changes in the prevalence of elevated fasting glucose along with worsening central obesity and prevalence of the metabolic syndrome are also present in the NHANES data (6) . Additionally, the decline with time in the prevalence of diabetes and elevated fasting glucose in cohort 1 is also unexpected but may be related to lower return rates among subjects who had diabetes or elevated fasting glucose.
Among diabetic individuals, the metabolic syndrome is less prevalent in cohort 1 than in cohort 2. In most studies but not in all (7), the prevalence is Ͼ80% (It is 84.3% in the NHANES III [26] .) A prevalence increase in the metabolic syndrome in diabetic subjects suggests that the increase in diabetes incidence is primarily driven not by genetic predisposition or sociodemographic factors but by metabolic disorders.
Our study has some limitations inherent to the SAHS design (two cohorts examined at two time points). One concern is that repeated measures of the same individuals are used for the analysis of trend. Cohorts at follow-up could have been enriched with participants with the metabolic syndrome. However, we have not noticed this potential source of bias. Furthermore, lower return rates are dem-onstrated in subjects with diabetes (cohort 1 men and women) or the metabolic syndrome (cohort 1 women). A second concern is the lack of waist circumference in cohort 1 baseline data. In this dataset, we have imputed waist circumference from weight and height using logistic regression equations. After testing this approach in cohort 1 follow-up data, we consider that the possibility of bias is small. Imputed waist circumference generates a slightly higher prevalence of the metabolic syndrome than measured waist circumference. Also, agreement between ATPIII-defined and imputed metabolic syndrome is very high.
In summary, the increase in the prevalence of the metabolic syndrome has had an adverse impact on CVD risk. Nevertheless, generalization of this finding may be problematic. Changes in HDL cholesterol levels and blood pressure partially explain the increase in CVD risk in San Antonio, but changes in HDL cholesterol levels and blood pressure have been different in the U.S. population. Therefore, further studies need to examine the impact of the metabolic syndrome on secular trends and regional differences in CVD risk in the U.S.
